Market Mover | Shares of Mpox-related Stocks Soar After the WHO Declared the Virus a Public Health Emergency of International Concern
Market Mover | Shares of Mpox-related Stocks Soar After the WHO Declared the Virus a Public Health Emergency of International Concern
August 19, 2024 - Shares of mpox-related Drug and Vaccine Developers rise on continued strength in early trading on Monday, $Virax Biolabs (VRAX.US)$ up over 155%, $Applied DNA Sciences (APDN.US)$ up nearly 114% and $GeoVax Labs (GOVX.US)$ up more than 52%.
2024年8月19日，星期一早盘，与MPOX相关的药物和生物-疫苗开发商的股票继续保持强劲上涨。 $Virax Biolabs (VRAX.US)$ 增长155%以上， $Applied DNA Sciences (APDN.US)$ 增长近114%，并且 $GeoVax Labs (GOVX.US)$ 增长超过52%。
Last Wednesday, WHO Director-General Tedros Adhanom Ghebreyesus declared that the mpox outbreak once again constituted a public health emergency of international concern (PHEIC). This is the second time relating to mpox since July 2022 that the WHO has issued such a highest-level alert. Caused by an Orthopoxvirus, mpox was first detected in humans in 1970, in the DRC. The disease is considered endemic to countries in Central and West Africa.
上周三，世界卫生组织总干事谭德塞宣布mpox疫情再次构成国际关注的公共卫生紧急状态(PHEIC)。这是自2022年7月以来，世界卫生组织第二次发出最高级别警报与mpox有关。mpox由正痘病毒引起，1970年在刚果民主共和国首次发现人类病例。该疾病被认为是中非和西非国家的地方病。
The number of suspected or confirmed mpox cases reported in Africa this year has already exceeded the total case count from last year. Currently, the mpox outbreak has extended beyond Africa, reaching Europe and Asia, with confirmed cases reported in Sweden and Pakistan.
今年非洲报告的疑似或确诊mpox病例已经超过去年总病例数。目前，mpox疫情已扩散到非洲以外的地区，影响到欧洲和亚洲，瑞典和巴基斯坦已经报告了确诊病例。
